{"database": "openregs", "table": "documents", "rows": [["FDA-2017-N-6373-0001", "FDA", "FDA-2017-N-6373", "Roxane Laboratories, Inc.; Withdrawal of Approval of a New Drug Application for ROXICODONE (Oxycodone Hydrochloride) Sustained-Release Tablets, 10 Milligrams and 30 Milligrams", "Notice", "Withdrawal", "2017-11-29T05:00:00Z", 2017, 11, "2017-11-29T05:00:00Z", null, "2017-11-29T16:30:15Z", "2017-25771", 0, 0, "0900006482cbbc78"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2017-N-6373-0001"], "units": {}, "query_ms": 63.99060308467597, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}